Paradigm Biopharmaceuticals Limited (ASX:PAR)
Australia
· Delayed Price · Currency is AUD 0.3000
+0.0250 (9.09%)
Apr 24, 2025, 4:10 PM AEST
ASX:PAR Revenue
Paradigm Biopharmaceuticals had revenue of 16.70K AUD in the half year ending December 31, 2024, with 254.56% growth. This brings the company's revenue in the last twelve months to 16.70K, down -454.56% year-over-year.
Revenue (ttm)
16.70K
Revenue Growth
-454.56%
P/S Ratio
6,995.73
Revenue / Employee
n/a
Employees
n/a
Market Cap
116.83M
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| CSL Limited | 24.61B |
| Pro Medicus | 184.58M |
| Cochlear | 2.31B |
| Sonic Healthcare | 9.33B |
| Telix Pharmaceuticals | 783.21M |
| Ramsay Health Care | 17.12B |
| Ansell | 3.00B |
| Mesoblast | 9.16M |